Skip to content

Spinal Cord Stimulation Versus Instrumentation for FBSS

sPinal coRd stimulatiOn coMpared With Lumbar InStrumEntation for Low Back Pain After Previous Lumbar Decompression (PROMISE): a Prospective Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05466110
Acronym
PROMISE
Enrollment
84
Registered
2022-07-20
Start date
2023-03-20
Completion date
2025-05-31
Last updated
2023-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Failed Back Surgery Syndrome, SCS, Neuromodulation, Spinal Cord Stimulation, Spinal Fusion, Low Back Pain

Brief summary

Low back pain affects people of all ages and has become the leading cause of living with disability worldwide. Patients, suffering from persistent pain after spinal surgery in the absence of any clear spinal pathology are defined of having a failed back surgery syndrome (FBSS) and treatment of FBSS remains a great controversy in the spinal community. Apart from conservative treatment, spinal fusion remains as therapeutic option. Furthermore, minimal invasive Neuromodulation techniques might be a promising alternative. Aim of this randomized interventional multi center study is to compare treatment success in FBSS patients with either spinal cord stimulation (SCS) or fusion surgery, 12 months after intervention according to the Oswestry Disability Index (ODI) and other scales and scores. Radiological and health economic outcome also will be analysed for thorough comparison of techniques. Additionally, the safety of the interventions needs to be compared.

Interventions

DEVICESpinal Cord Stimulation

Epidural application of electrical current to the spinal cord

screw-rod system based spinal instrumentation

Sponsors

Boston Scientific Corporation
CollaboratorINDUSTRY
University Hospital Augsburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * Symptomatic degenerative disc disease with LBP as a predominant symptom for at least 6 months following pervious surgery for disc herniation * ODI score at least 21 * Correctly signed informed consent form

Exclusion criteria

* Spinal stenosis resulting in spinal claudication or neurological deficits * Spinal Instability (\> 3 mm Motion on dynamic Lumbar X-rays) * Major psychiatric disorder

Design outcomes

Primary

MeasureTime frameDescription
Oswestry disability index / ODI12 months after interventionA patient reported outcome measure to rate pain and disability

Secondary

MeasureTime frameDescription
Adverse events12 months after interventionComparison of complication rates
SF3612 months after interventionScore to assess quality of life
EuroQOL 5D12 months after interventionScore to assess quality of life
Crossover rates12 months after interventionRates of crossover to another therapy arm
Pain medication12 months after interventionAmount of analgesics taken (drug, dose, mode of application)
hospital length of staythrough study completion, an average of 2 yearsTime measured in days, counting from the first day of hospitalization until the day of discharge of the hospitalization the surgical intervention was performed. If surgery is performed as staged procedure in two separate hospitalizations (SCS) both hospitalizations are counted as described above and days are summed up.

Countries

Germany

Contacts

Primary ContactEhab Shiban, MD
ehab.shiban@uk-augsburg.de0049 / (0)821 / 400-2251
Backup ContactPhilipp Krauss, MD
philippemanuel.krauss@uk-augsburg.de0049 / (0)821 / 400-2251

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026